Activated Peritoneal Cavity B-1a Cells Posses Regulatory B Cell Properties

Publication date

2014-02

Authors

Margry, B.ISNI 000000039483426X
Kersemakers, S.C.W.
Hoek, A.ISNI 0000000388042549
Arkesteijn, G.J.A.
Wieland, W.H.ISNI 000000039865440X
van Eden, W.ISNI 000000010963944X
Broere, F.ORCID 0000-0001-9343-0111ISNI 0000000388807652

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

Abstract

Previous studies have suggested that murine peritoneal cavity-derived B-1a cells possess similarities with described regulatory B cell subsets. The aim of the current study was to examine the potential immunoregulatory function of peritoneal cavity-derived B(-1a) cells. In vitro activation of peritoneal cavity-derived B- and B-1a cells shows that activation of these B cells with anti-CD40 and LPS induces these cells to secrete more IL-10, IL-6 and IgM as compared to splenic B cells. In a suppression assay, CD40/TLR4-activated peritoneal cavity B cells possess regulatory B cell functions as they inhibit the capacity of CD4+ T cells to produce both tumor necrosis factor-α and interferon-γ. Splenic B cells did not show this, whereas non-activated peritoneal cavity B cells augmented the capacity of CD4+ T cells to produce tumor necrosis factor-α, while the ability to produce interferon-γ was not altered. The current paper compares splenic B cells to peritoneal cavity B(-1a) cells in an in vitro activation- and an suppression-assay and concludes that peritoneal cavity B(-1a) cells possess properties that appear similar to splenic autoimmune-suppressive regulatory B cell subsets described in the literature.

Keywords

Citation

Margry, B, Kersemakers, S C W, Hoek, A, Arkesteijn, G J A, Wieland, W H, van Eden, W & Broere, F 2014, 'Activated Peritoneal Cavity B-1a Cells Posses Regulatory B Cell Properties', PLoS One, vol. 9, no. 2, e88869, pp. 1-8. https://doi.org/10.1371/journal.pone.0088869